Literature DB >> 24222356

MicroRNAs in Cancer.

Jianzhong Jeff Xi1.   

Abstract

MicroRNAs (miRNAs) are a group of endogenous, small noncoding RNAs of approximately 22 nucleotides in lengths. As a new class of signaling modulators, miRNAs have attracted great attention for their unique features, including multitarget regulation, tissue specificity, and evolutionary conservation. These small endogenous RNAs are able to interact with many important genes and play critical roles in a wide range of biological processes, including cell proliferation and differentiation. Strikingly, miRNAs are frequently dysregulated in human cancers. A number of studies have shown that miRNAs are involved in cancer pathogenesis by regulating oncogenes or tumor suppressor genes. Here, we review recent studies of miRNAs in cancer development and discuss their potential applications in cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24222356     DOI: 10.1007/978-3-642-31659-3_5

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  21 in total

1.  MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas.

Authors:  Jin Qian; Rui Li; Ying-Yi Wang; Yan Shi; Wen-Kang Luan; Tao Tao; Jun-Xia Zhang; Yi-Chang Xu; Yong-Ping You
Journal:  Mol Cell Biochem       Date:  2015-02-04       Impact factor: 3.396

2.  Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.

Authors:  A Kroiss; S Vincent; M Decaussin-Petrucci; E Meugnier; J Viallet; A Ruffion; F Chalmel; J Samarut; N Allioli
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

3.  Copy number variable microRNAs in schizophrenia and their neurodevelopmental gene targets.

Authors:  William Warnica; Daniele Merico; Gregory Costain; Simon E Alfred; John Wei; Christian R Marshall; Stephen W Scherer; Anne S Bassett
Journal:  Biol Psychiatry       Date:  2014-05-29       Impact factor: 13.382

4.  Involvement of APRIL in Helicobacter pylori-related gastric cancer.

Authors:  Qun Zhang; Ying Ni; Xiaofei Zhi; Jiwei Wang; Zheng Li; Jie Tang; Linjun Wang; Weizhi Wang; Zekuan Xu
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-18       Impact factor: 4.553

5.  Association between miR-146aG>C and miR-196a2C>T polymorphisms and the risk of hepatocellular carcinoma in a Chinese population.

Authors:  Bing Zhou; Liang-Peng Dong; Xiao-Yue Jing; Jin-Song Li; Shu-Juan Yang; Jun-Ping Wang; Long-Feng Zhao
Journal:  Tumour Biol       Date:  2014-05-10

Review 6.  Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects.

Authors:  Daniel Neureiter; Tarkan Jäger; Matthias Ocker; Tobias Kiesslich
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

7.  miR-1303 targets claudin-18 gene to modulate proliferation and invasion of gastric cancer cells.

Authors:  Shi-jie Zhang; Jian-fang Feng; Lei Wang; Wei Guo; Yu-wen Du; Liang Ming; Guo-qiang Zhao
Journal:  Dig Dis Sci       Date:  2014-03-20       Impact factor: 3.199

8.  miR-106b-5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell carcinoma.

Authors:  Wei Xiang; Jun He; Chao Huang; Lejun Chen; Dan Tao; Xinchao Wu; Miao Wang; Gang Luo; Xingyuan Xiao; Fuqing Zeng; Guosong Jiang
Journal:  Oncotarget       Date:  2015-02-28

9.  MiR-212 exerts suppressive effect on SKOV3 ovarian cancer cells through targeting HBEGF.

Authors:  Li-Qiang Wei; Hui-Tao Liang; Dong-Chun Qin; Hui-Fang Jin; Yong Zhao; Ming-Cong She
Journal:  Tumour Biol       Date:  2014-09-09

10.  miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression.

Authors:  Nengwang Yu; Shuai Fu; Yubao Liu; Zhonghua Xu; Yi Liu; Junwen Hao; Baocheng Wang; Aimin Zhang
Journal:  J Exp Clin Cancer Res       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.